The Shifting Tech Landscape of eTMF: The Failed Promises of Digitizing Clinical Processes, and Where to Go from Here

Session details:

Despite claims that digitization would enable life science companies to move faster, reduce manual work, and save money, new drugs take longer than ever to get approved, and TMF management has never been more expensive. This session will assess how we got into this mess… and how to get out of it. 
In this session we will cover:

• The history of digitizing TMF management
• The challenges posed by the current vendor landscape
• What Sponsors and CROs should look for when evaluating legacy and new generation technology providers